Bristol Myers Squibb to Host Virtual Investor Event to Discuss ESC 2022 Highlights

Rhea-AI Summary

Bristol Myers Squibb (NYSE: BMY) announced a virtual Investor Event on August 28, 2022, at 7:00 p.m. CET / 1:00 p.m. ET. The event will discuss data from the AXIOMATIC-SSP Phase 2 trial of milvexian for secondary stroke prevention presented at the European Society of Cardiology Congress 2022 in Barcelona, Spain. Executives will offer insights on the data and answer investor questions. Interested parties can access the live webcast on the company's investor relations website, with archived content available later the same day.

NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will host a virtual Investor Event on Sunday, August 28, 2022, at 7:00 p.m. CET/ 1:00 p.m. ET to discuss data from the AXIOMATIC-SSP Phase 2 trial of milvexian in secondary stroke prevention presented at the European Society of Cardiology Congress 2022 in Barcelona, Spain.

Company executives will provide an overview of data presented and address questions from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Material related to the company’s presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20220803005877/en/

Bristol Myers Squibb

Media:

media@bms.com

Investor Relations:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

When is Bristol Myers Squibb's Investor Event?

The Investor Event is scheduled for August 28, 2022, at 7:00 p.m. CET / 1:00 p.m. ET.

What will be discussed at the Bristol Myers Squibb event?

The event will focus on data from the AXIOMATIC-SSP Phase 2 trial of milvexian in secondary stroke prevention.

Where is the European Society of Cardiology Congress 2022 held?

The Congress is taking place in Barcelona, Spain.

How can I access the Bristol Myers Squibb Investor Event?

The event can be accessed via a live webcast on their investor relations website at investor.bms.com.

Will the Bristol Myers Squibb presentation be available later?

Yes, an archived edition of the presentation will be available later on the same day.